Since the clinical experiment of drug clinical experiments last year，After many varieties continue to withdraw clinical trials，Each variety of obtained varieties seems precious。The following is a comment made by the Saibailan special author on the drug approval situation in the first half of this year.，Among the 89 varieties approved，The author also selected 6 varieties he thinks the most valuable，Find varieties for the market or agent，can be regarded as a reference。

 

  Xianda Data V3.2 Discovery，A total of 89 new approvals published by the Pharmaceutical Supervision Bureau in the first six months of 2016，It can be described as the least approved year in the past years。Biological products are not approved in one。

 

  From the perspective of drug classification，The approved products announced by CFDA are chemicals，6 categories of drugs have the most batch，84%of the overall number of approval，Followed by the non -imitation。

 

  The newly approved exclusive products in 2016 are apple acid Nonoshaxing capsules and ginger phenol soft capsules。It can be seen that since the launch of clinical self -examination,，Difficulty in approval of drugs，The number of exclusive products is approved and less and less。Xianda Data V3.2 The products that are worthy of attention are 6。

 

  Apple sour Ninoshaxing Capsule

 

  Declaration Type: Old Category of Chemistry Pharmaceuticals 1.1 New drugs

 

  Indications: It is used stake betting appstake sports betting appstake sports bettingto treat communities to gain sex pneumonia.

 

  Batch type: Capsules

 

  Batch specifications: 0.25g (with Nono Steak)

 

  Manufacturer: Zhejiang Pharmaceutical Co., Ltd. Xinchang Pharmaceutical Factory

 

  Background: According to Xianda Data V3.2，Apple acid Nonohastan and its capsules were declared clinical in 2006，Yuhuayu (Wuxi) Pharmaceutical Co., Ltd. and Taijing Pharmaceutical R & D (Beijing) Co., Ltd.。In 2013, it was changed by Zhejiang Pharmaceutical Co., Ltd. Xinchang Pharmaceutical Factory and Taijing Pharmaceutical R & D (Beijing) Co., Ltd.。

 

  Zhejiang Pharmaceuticals purchased its new drugs & ldquo; Nono Stephen & RDQUO;，Sign signed a contract 8 million US dollars，Oral dosage forms will pay a milestone cost of $ 1 million within 15 days from the date of obtaining the drug approval number。In addition，Zhejiang Pharmaceuticals also need to pay fees，According to the net sales of the product product, the patent permit fee is paid to the Taijing with a ratio of 7%-11%、Technical trick use fee and new drug technology transfer fee。

 

  Price: Great Pharmaceutical Pharmaceutical Market potential，2015 hospital sample market over 1.7 billion yuan，The best sales currently selling is Levofloxacin。The market size competition is equally intense，For example, Jimmy Shaxing、The number of manufacturers of Moshaxing is within 3。

 

  Ginger Total Pheno -soft capsules

 

  Declaration type: 5 new medicines of Chinese medicine

 

  Indications: Treatment of faint disease，Chinese medicine syndrome differentiation is stomach qi deficiency、Patients with phlegm -turbidity obstruction。

 

  Batch type: soft capsule

 

  Batch specifications: 0.3g per grain (including 30 mg of ginger total phenol)

 

  Manufacturer: Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd.

 

  Background: Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd. also obtained the production approval document and drug GMP certificate (certificate number: HN20160186)。This product was released by the Institute of Research and Radiation Medicine of the Chinese Academy of Military Medical Sciences of the Chinese People's Liberation Army、Jiangxi Jiangzhong Pharmaceutical (Group) Co., Ltd. transferred to Hunan Sanjin。

 

  Evaluation: The corresponding dosage form of the effective ingredient of Chinese medicine is an important direction for modern production of Chinese medicine，But the most difficult thing now is that the hospital'stake sports betting appstake sports betting appstake betting apps drug difficulties and non -medical insurance products are difficult to sell in the hospital。The main channel for the drug of Sanjin is OTC，As a prescription medicine，The marketing direction of this product may be the main pharmacy outside the hospital。

 

  Sodium sodium sodium in injection

 

  Application type: Chemical drug supplement application

 

  Indications: The lower respiratory tract for sensitive bacteria、urinary tract、Gallbladder、Abdominal cavity、pelvic cavity、Skin soft tissue and bone and joint infections，It is also used for sepsis and meningitis。

 

  Batch type: injection

 

  Batch specifications: 1.5G (C18H18N8O7S3 1.0G and C8H11NO5S 0.5G) and 0.75g (C18H18N8O7S3 0.5G and C8H11NO5S 0.25g)

 

  Manufacturer: Xiangbei Wilman Pharmaceutical Co., Ltd.

 

  Background: The specifications that Wilman, Xiangbei Wilman was previously approved was 3.0g (C18H18N8O7S3 2.0g and C8H11NO5S 1.0g)，Now 2 new specifications。

 

  Evaluation: Sodium sodium sodium sodium in injection in the market sales of sample hospitals，2015 Sample Hospital sales are not more than 10 million, only 4 million，But sales in individual provinces are reported that the sales potential for sales due to exclusive general names。

 

  The main risk of antibiotics injection is that the outpatient clinic is not allowed to hang water.，Only the antibiotics oral medication。In addition，Enzyme -containing antibiotics are also products that are strictly controlled by antibiotics in individual provinces。

 

  Calcium carbonate D3 particles

 

  Application type: Chemical drug supplement application

 

  Indications: For women for pregnancy and lactation、Menopausal Women、Calcium supplements from the elderly, etc.，help the prevention and control of osteoporosis。

 

  Batch type: Granules

 

  Batch specifications: each bag contains 0.25g/vitamin D32.5ug (100 international unit)

 

  Manufacturer: Beijing Kangyuan Pharmaceutical Co., Ltd.

 

  Background: Beijing Kangyuan Pharmaceutical Co., Ltd. exclusive product adds 1 small specification，Original specifications per bag containing calcium 500mg/vitamin D35ug (200 international unit)。

 

  Evaluation: Calcium carbonate D3 particles are mainly OTC channel products，Granules are very suitable for children to use。Ultratab Laboratories，Inc. There is also an exclusive dosage type product called pediatric calcium carbonate D3 particles，Specifications are 750mg of calcium carbonate (equivalent to 300mg of calcium)，Vitamin D3100IU (2.5ug)。

 

  Atorvastatin calcium scattered tablets

 

  Application type: Chemical drug supplement application

 

  stake sports betting appstake sports betting appIndications: Patients with primary hypertrophic lesions，Including family hypercholesteroemia (hybrids) or hybrid hyperlipidemia (equivalent to IIA and IIB types of Fredrickson classification method)，If diet therapy and other non -drug therapy are not satisfactory，Apply this product to treat its total cholesterol increase、Low density lipoprotein cholesterol elevation、Big increased lipoprotein B and elevated triglyceride。 Patients with patients with hypercholesteroliamia in purehezi，Atorvastatin calcium can be used or used alone with other lipid -lowering therapy (when there are no other treatment methods)，To reduce total cholesterol and low density lipoprotein cholesterol。

 

  Batch dosage type: Disposum tablets

 

  Batch specifications: 20mg (with C33H35FN2O5)

 

  Manufacturer: Guangdong Encyclopedia Pharmaceutical Co., Ltd.

 

  Background: The exclusive product of Guangdong Encyclopedia increases 1 large specification，Original specifications 10mg。

 

  Evaluation: Xianda Data v3.2 Discovery，Atropine's sample market sales in my country's hospitals exceeded 1 billion yuan，Among them, Pfizer's market share accounted for a relatively large。Atorvastatin calcium decentralized tablets are exclusive dosage forms，Tianfang's Atropine Calcium Capsule is also an exclusive dosage form。It is expected that the biggest risk of this improved product is consistency evaluation。

 

  Elioprazole sodium for injection

 

  Declaration Type: Old Class 6 Class 6 Class 6 Imitation Drugs

 

  Indications: (1) When oral therapy is not applicable，alternative therapy for gastroesophageal reflux disease。(2) Low-risk patients who are used for acute gastric or duodenal ulcer bleeding for oral therapy (Forrest grading Ⅱc-Ⅲ)。

 

  Manufacturer: Jiangsu Aoly Kang Pharmaceutical Co., Ltd. and Zhengda Tianqing Pharmaceutical Group Co., Ltd.

 

  Batch type: injection

 

  Specification: 40mg，Zhengda Tianqing Pharmaceutical Group Co., Ltd. 20mg and 40mg

 

  Background: Earlier in the injection, the original medicine Astrise's family was approved，The first imitation of the first imitations will break the landscape of Astraon's many years in the market。

 

  Evaluation: The market potential of proton pump inhibitors injection has always been great，2015 sample hospital market size is close to 4 billion yuan。Astrikon's injection for Elite Omepazole Sodium 2015 Sample Hospital size is 450 million yuan。Zhengda Tianqing's 20mg specification stake sports betting appstake online sports bettingStake Sports Bettingof the original research manufacturer, Astrikang, has never been listed in our country，It is exclusive specification。The main risk of this product is that the proton pump inhibitors injection is the auxiliary medication list of individual provinces or strict control of the product on the list of lists.，such as Anhui。